Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Weidemann

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Plos Neglected Tropical Diseases|October 10, 2017
Analysing published global Ebola Virus Disease research using social network analysisChristiane Hagel, Felix Weidemann, Stephan Gauch, et al.
Vaccine|July 22, 2014
Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approachFelix Weidemann, Manuel Dehnert, Judith Koch, et al.
Statistics in Medicine|May 14, 2014
Bayesian parameter inference for dynamic infectious disease modelling: rotavirus in GermanyFelix Weidemann, Manuel Dehnert, Judith Koch, et al.
BMC Health Services Research|September 28, 2013
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in GermanyBernhard Ultsch, Felix Weidemann, Thomas Reinhold, et al.
BMC Infectious Diseases|April 13, 2017
Is the impact of childhood influenza vaccination less than expected: a transmission modelling studyFelix Weidemann, Cornelius Remschmidt, Silke Buda, et al.
The Pediatric Infectious Disease Journal|May 31, 2018
Group B Streptococci: Declining Incidence in Infants in GermanyEsther Wicker, Fabian Lander, Felix Weidemann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in GermanyStefan M Scholz, Felix Weidemann, Oliver Damm, et al.
Lipids in Health and Disease|May 16, 2020
Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional studyAdrian Rosada, Ursula Kassner, Felix Weidemann, et al.
Vaccine|April 26, 2016
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in GermanyHannah Christensen, Tom Irving, Judith Koch, et al.
Vaccine|February 25, 2014
Cost-effectiveness of childhood rotavirus vaccination in GermanyPamela Aidelsburger, Kristin Grabein, Katharina Böhm, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos Neglected Tropical Diseases|October 10, 2017
Analysing published global Ebola Virus Disease research using social network analysisChristiane Hagel, Felix Weidemann, Stephan Gauch, et al.
Vaccine|July 22, 2014
Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approachFelix Weidemann, Manuel Dehnert, Judith Koch, et al.
Statistics in Medicine|May 14, 2014
Bayesian parameter inference for dynamic infectious disease modelling: rotavirus in GermanyFelix Weidemann, Manuel Dehnert, Judith Koch, et al.
BMC Health Services Research|September 28, 2013
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in GermanyBernhard Ultsch, Felix Weidemann, Thomas Reinhold, et al.
BMC Infectious Diseases|April 13, 2017
Is the impact of childhood influenza vaccination less than expected: a transmission modelling studyFelix Weidemann, Cornelius Remschmidt, Silke Buda, et al.
The Pediatric Infectious Disease Journal|May 31, 2018
Group B Streptococci: Declining Incidence in Infants in GermanyEsther Wicker, Fabian Lander, Felix Weidemann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in GermanyStefan M Scholz, Felix Weidemann, Oliver Damm, et al.
Lipids in Health and Disease|May 16, 2020
Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional studyAdrian Rosada, Ursula Kassner, Felix Weidemann, et al.
Vaccine|April 26, 2016
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in GermanyHannah Christensen, Tom Irving, Judith Koch, et al.
Vaccine|February 25, 2014
Cost-effectiveness of childhood rotavirus vaccination in GermanyPamela Aidelsburger, Kristin Grabein, Katharina Böhm, et al.
Pageof 2